Article Text

Download PDFPDF
Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies
  1. F Andreotti,
  2. I Porto,
  3. F Crea,
  4. A Maseri
  1. Institute of Cardiology, Catholic University, Rome, Italy
  1. Correspondence to:
    Dr F Andreotti, Cardiology, Catholic University, 00168 Rome, Italy;


Inflammation and genetics are both prominent mechanisms in the pathogenesis of atherosclerosis and arterial thrombosis. Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) α and β, transforming growth factors (TGF) β1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1. Although they are very preliminary and partly conflicting, the data provide some evidence that alterations in the genetics of the inflammatory system may modify the risk of ischaemic heart disease.

  • inflammation
  • genes
  • polymorphisms
  • myocardial infarction
  • atherosclerosis
  • CI, confidence interval
  • ECTIM, étude cas-témoin de l'infarctus du myocarde
  • IHD, ischaemic heart disease
  • IL, interleukin
  • IL 1ra, interleukin 1 receptor antagonist
  • OR, odds ratio
  • PECAM, platelet endothelial cell adhesion molecule
  • TGF, transforming growth factor
  • TNF, tumour necrosis factor
  • VNTR, variable number of tandem repeats

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


Linked Articles

  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society